Select your country

Africa
Asia
Europe
Latin America
North America
Oceania

Q2 2018 Conference calls for the media and for analysts

Merck KGaA, Darmstadt, Germany, today reported solid organic sales growth for the second quarter of 2018 and a slight increase in sales despite considerably negative foreign exchange effects.

09 Aug 2018

From 07:00 to 15:00

MERCK KGAA, DARMSTADT, GERMANY, REPORTS SOLID ORGANIC PERFORMANCE IN Q2 2018

  • Slight increase in Group sales, slowed down by exchange rate effects
  • Life Science and Healthcare drive organic sales growth of 5.2%
  • EBITDA pre decreases by –13.7%, impacted primarily by exchange rate effects (–11.0%)
  • Merck KGaA, Darmstadt, Germany, confirms forecast for organic development of sales and EBITDA pre

Solid organic sales growth

In the second quarter, our company generated ."solid organic sales growth, which was mainly attributable to our Life Science and Healthcare business sectors. This also reflects the positive contributions of our new medicines Bavencio and Mavenclad. Performance Materials also generated slight organic sales growth owing to the strong development of Semiconductor Solutions."
(Stefan Oschmann, Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany)

Related News

View All News

Press Releases

Merck KGaA, Darmstadt, Germany, Reports Solid Organic Performance in Q ...

Merck KGaA, Darmstadt, Germany, today reported solid organic sales growth for the second quarter of 2018 and a slight increase in sales despite considerably negative foreign exchange effects.

2018/08/09

Markus Talanow

Financial Communications

Constantin Fest

Head of Investor Relations

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement